CIITA and MHC class II deficiency: A requirement of MHC class II expression for the establishment of a functional peripheral B cell tolerance checkpoint was first suggested by the study of a patient with classical BLS with CIITA gene mutations and a low CD4+ T cell count, who showed accumulation of self-reactive mature naive B cells (40).